Gara Jalqabaatti › COPD › Texas › Dallas
Qorannoo klinikaalii COPD Dallas, TX keessatti
Qorannoo 13 COPD f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Dallas
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Dallas
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Namoota walitti qabaa jiraSadarkaa 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Namoota walitti qabaa jiraSadarkaa 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Namoota walitti qabaa jira
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Namoota walitti qabaa jiraSadarkaa 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Namoota walitti qabaa jiraSadarkaa 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Liver Center of Texas, Dallas
Qorannoo COPD magaalota biroo keessatti
- Philadelphia, PAQorannoo 24
- Miami, FLQorannoo 18
- Birmingham, ALQorannoo 17
- Boston, MAQorannoo 17
- Houston, TXQorannoo 16
- Baltimore, MDQorannoo 15
- Orlando, FLQorannoo 15
- Chicago, ILQorannoo 15
- Pittsburgh, PAQorannoo 12
- New York City, NYQorannoo 11
- Ann Arbor, MIQorannoo 10
- Winston-Salem, NCQorannoo 10
Qorannoo biroo Dallas keessatti
- Saree OljooQorannoo 55
- Kansara Qara'a Non-Small CellQorannoo 52
- Kansara MetastatikiiQorannoo 42
- Cufama OnneeQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ProstateQorannoo 36
- Kansarii ColorectalQorannoo 33
- ObesityQorannoo 30
- Kansarii OvariiQorannoo 28
- Dhibee QaraQorannoo 27
- Dukkana BladderQorannoo 27
- Kansa EndometiriyaaliiQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.